Eplas.Is

EPLAS.IS has a market price of 6.05 TRY and a market capitalization of 1,153,222,099.15 TRY, with a price-to-book ratio of 0.34 and a price-to-tangible-book ratio of 0.34. The company's enterprise value to EBITDA is negative at -12.41, indicating a loss-making position, while the enterprise value to revenue is 0.59, suggesting a relatively low valuation compared to its revenue. The company's return on equity is -5.77%, and its return on assets is -3.85%, both of which are below the industry median for profitability metrics.

The company's liquidity position is characterized by a current ratio of 0.51, indicating that it has less than half the current assets to cover its current liabilities. The debt-to-equity ratio is 0.06, suggesting a relatively low level of leverage compared to industry peers. However, the company's operating cash flow is negative at -170,209,650 TRY, and its free cash flow is also negative at -149,416,510 TRY, indicating a cash outflow from operations.

EPLAS.IS has a total revenue of 2,246,195,610 TRY, with a gross profit of 346,876,070 TRY. The company's operating income is negative at -107,266,880 TRY, and its net income is also negative at -192,884,270 TRY. The company's capital expenditure is -80,165,360 TRY, indicating a reduction in capital spending. The company's revenue concentration is not disclosed, but the industry typically has moderate to high concentration in key markets.

The company's outlook for the current fiscal year is negative, with a projected decline in revenue and profitability. The next fiscal year is expected to show a similar trend, with no significant improvement in the near term. The company's risk assessment indicates a medium liquidity risk and a low dilution risk, but the key flag of negative net cash after subtracting total debt suggests potential liquidity constraints.

Recent events and filings indicate that the company is facing operational challenges, as reflected in its negative operating and net income. The company's financial statements show a decline in profitability and cash flow, which may impact its ability to meet short-term obligations. The company's management has not disclosed any significant strategic initiatives or cost-saving measures to address these challenges.

The company's risk assessment highlights a medium liquidity risk, primarily due to its negative operating cash flow and free cash flow. The company's debt-to-equity ratio is low, but the negative net cash position after subtracting total debt indicates potential liquidity constraints. The company's dilution risk is low, but the risk of further dilution remains if the company needs to raise additional capital to fund operations or reduce debt.